Глипвило

Глипвило (Vildagliptin) is an oral antidiabetic medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to the DPP-4 inhibitor class and helps regulate insulin production. Suitable for patients seeking adjunct therapy alongside diet and exercise. A reliable option for type 2 diabetes management.

Vildagliptin is prescribed to improve blood sugar control in adults diagnosed with type 2 diabetes. It works by increasing the release of insulin when blood sugar is high and reducing the amount of sugar made by the liver. Often used alongside diet and exercise for better results. This medication is not intended for type 1 diabetes or diabetic ketoacidosis.

Vildagliptin helps maintain steady blood sugar levels throughout the day, reducing spikes after meals. Many users report improved energy and reduced fatigue associated with high blood sugar. It may also support weight stability when combined with lifestyle changes. Some individuals notice fewer sugar cravings over time.

Store Vildagliptin at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications and conditions before starting this treatment. Avoid crushing or splitting tablets unless advised by a medical professional.

Vildagliptin may interact with other diabetes medications, including insulin or sulfonylureas, increasing the risk of low blood sugar. Alcohol consumption can affect blood sugar levels and may intensify side effects. Inform your doctor about all prescription, over-the-counter, and herbal products you use. Certain kidney or liver conditions may require dose adjustments.